Chemistry: analytical and immunological testing – Including use of radioactive properties
Reexamination Certificate
2011-08-30
2011-08-30
Gakh, Yelena (Department: 1777)
Chemistry: analytical and immunological testing
Including use of radioactive properties
C436S536000, C422S050000, C435S004000, C435S007100, C435S007800
Reexamination Certificate
active
08008083
ABSTRACT:
The present invention discloses a method for diagnosing a cardiac complication in a patient due to coronary catheterization, comprising the steps of (a) obtaining at least one baseline sample from the patient during or after coronary catheterization, and then (b) obtaining at least one test sample from the patient after coronary catheterization, (c) determining a change of the level of an ANP-type peptide between the baseline sample and the test sample, wherein a significant decrease in the level of the ANP-type peptide according to step c) indicates a cardiac complication.
REFERENCES:
patent: 5744305 (1998-04-01), Fodor et al.
patent: 7358055 (2008-04-01), Valkirs et al.
patent: 2002/089657 (2002-11-01), None
patent: 2002/083913 (2004-10-01), None
patent: 2006/087373 (2006-08-01), None
International Search Report issued Nov. 7, 2007 in PCT Application No. PCT/EP2007/059597.
International Preliminary Report on Patentability issued Nov. 7, 2008 in PCT Application No. PCT/EP2007/059597.
Abbas, Syed A. et al., Factors Associated with the Release of Cardiac Troponin T Following Percutaneous Transluminal Coronary Angioplasty, Clinical Cardiology, 1996, pp. 782-786, vol. 19.
Ala-Kopsala, Minna et al., Molecular Heterogeneity Has a Major Impact on the Measurement of Circulating N-Terminal Fragments of A- and B-Type Natriuretic Peptides, Clinical Chemistry, 2004, pp. 1576-1588, vol. 50, No. 9.
Bonow, Robert O., New Insights Into the Cardiac Natriuretic Peptides, Circulation, 1996, pp. 1946-1950, vol. 93.
Brueckmann, Martina et al., N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias, Clinical Chemistry and Laboratory Medicine, 2004, pp. 896-902, vol. 42, No. 8.
Costello, John M. et al., Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children, The Journal of Thoracic and Cardiovascular Surgery, Sep. 2005, pp. 822-829, vol. 130, No. 3.
Frigerio, Maria et al., Prevention and Management of Chronic Heart Failure in Management of Asymptomatic Patients, American Journal of Cardiology, May 8, 2003, pp. 4F-9F, vol. 91 (supplement), No. 9A.
Maisel, Alan S. et al., Cardiac biomarkers: a contemporary status report, Nature Clinical Practice, Jan. 2006, pp. 24-34, vol. 3, No. 1.
Mueller, Thomas et al., Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples, Clinical Chemistry Laboratory Medicine, 2004, pp. 942-944, vol. 42, No. 8.
Nolan, John P. and Skylar, Larry A., Suspension array technology: evolution of the flat-array paradigm, Trends in Biotechnology, Jan. 2002, pp. 9-12, vol. 20, No. 1.
Ricciardi, Mark J. et al., Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation, Circulation, 2001, pp. 2780-2783, vol. 103.
Saadeddin, Salam M. et al, Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting, Medical Science Monitor, 2000, pp. 708-712, vol. 6, No. 4.
Saleh, Nawsad et al., Usefulness of Preprocedural Serum N-Terminal Pro-Brain Natriuretic Peptide Levels to Predict Long-Term Outcome After Percutaneous Coronary Intervention in Patients With Normal Troponin T Levels, The American Journal of Cardiology, 2006, pp. 830-834, vol. 97.
Sundsfjord, J. A. et al., Identification and Plasma Concentrations of the N-Terminal Fragment of Proatrial Natriuretic Factor in Man, Journal of Clinical Endrocrinology and Metabolism, Mar. 1988, pp. 605-610, vol. 66, No. 3.
Tateishi, Jun et al., Transient Increase in Plasma Brain (B-Type) Natriuretic Peptide after Percutaneous Transluminal Coronary Angioplasty, Clinical Cardiology, 2000, pp. 776-780, vol. 23.
Wu, Alan H. B. et al., Analytical and Clinical Evaluation of the Bayer ADVIA Centaur Automated B-Type Natriuretic Peptide Assay in Patients with Heart Failure: A Multisite Study, Clinical Chemistry, 2004, pp. 867-873, vol. 50, No. 5.
Hess Georg
Horsch Andrea
Zdunek Dietmar
Gakh Yelena
Roche Diagnostics Operations Inc.
Xu Robert
LandOfFree
Natriuretic peptides for diagnosing cardiac complications... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Natriuretic peptides for diagnosing cardiac complications..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Natriuretic peptides for diagnosing cardiac complications... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2671161